DSPE-PEG2000-Mal (ammonium)

DSPE-PEG-Maleimide has DSPE phospholipid and maleimide to prepare nanostructured lipid carrier. DSPE-PEG-Maleimide extends blood circulation time and higher stability for encapsulated agents[1][2].

Product Specifications

CAS Number

[474922-22-0]

Product Name Alternative

DSPE-PEG2000 Maleimide (ammonium) ; 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-N-[maleimide (polyethylene glycol) -2000] (ammonium)

UNSPSC

12352200

Hazard Statement

H315, H319

Target

Liposome

Type

Biochemical Assay Reagents

Related Pathways

Metabolic Enzyme/Protease

Field of Research

Others

Assay Protocol

https://www.medchemexpress.com/dspe-peg2000-mal-ammonium.html

Purity

95.0

Solubility

DMF : 50 mg/mL (ultrasonic)

Smiles

O=C(NCCOP(O)(OC[C@@H](COC(CCCCCCCCCCCCCCCCC)=O)OC(CCCCCCCCCCCCCCCCC)=O)=O)OCCOCCNC(CCN1C(C=CC1=O)=O)=O.N.[n]

Molecular Formula

(C2H4O) nC51H92N3O13P.H3N

Molecular Weight

2000 (Average)

Precautions

H315, H319

References & Citations

[1]Schnorenberg MR, et, al. Synthesis and Purification of Homogeneous Lipid-Based Peptide Nanocarriers by Overcoming Phospholipid Ester Hydrolysis. ACS Omega. 2018 Oct 31;3 (10) :14144-14150. |[2]Huwyler J, et, al. Brain drug delivery of small molecules using immunoliposomes. Proc Natl Acad Sci U S A. 1996 Nov 26;93 (24) :14164-9.